A Mohali laboratory has developed a novel cancer treatment method based on nanoparticles. This method, which is more effective than traditional methods, has the potential to become an adjuvant or alternative cancer therapy.

The nanoparticles can specifically target and kill cancer cells while leaving healthy cells alone, resulting in tumor eradication within a month of treatment. Vitamin-K3-loaded copper zinc ferrite nanoparticles with therapeutic properties are used in these nanoparticles.

Cancer treatments such as chemotherapy, radiation, and surgery have limitations such as drug resistance and side effects. Thus, the development of nanotherapies capable of effectively targeting hypoxic tumors while causing minimal side effects is critical.

The new treatment integrates magnetic hyperthermia-based cancer therapy and chemo-dynamic therapy to generate toxic radicals for killing cancer cells.

This innovation responds to the growing global cancer cases, projected to increase by 12.8% in India by 2025.

According to the researchers, combining these techniques causes irreversible oxidative damage to tumor cells, resulting in tumor eradication. "The synergistic anticancer response resulted from the combined effect." "Within 20 days of MTD treatment, a tumor inhibition rate of 69 percent was achieved, and complete tumor eradication was achieved within 30 days," the researchers reported.

The findings of the INST scientists have been published in Applied Materials and Interfaces, a peer-reviewed scientific journal published by the American Chemical Society.